GenoPalate Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$250K
- Investors
-
6
GenoPalate General Information
Description
Developer of a genetic data analytics platform designed to empower customers to eat healthy by assessing their genes. The company's platform offers a proprietary analysis of genome-wide nutrigenetic profiles from partnered or third-party labs-collected genomic DNA data to develop a line of digital and physical personalized nutrition products, enabling customers to get a comprehensive report about their distinctive nutrition needs.
Contact Information
Website
www.genopalate.comCorporate Office
- 10437 West Innovation Drive
- Suite 518
- Milwaukee, WI 53226
- United States
Corporate Office
- 10437 West Innovation Drive
- Suite 518
- Milwaukee, WI 53226
- United States
GenoPalate Timeline
GenoPalate Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 04-Mar-2026 | $250K | Completed | Generating Revenue | ||
| 6. Later Stage VC | 10-Dec-2024 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 4. Later Stage VC (Series A) | 21-Oct-2022 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 30-Dec-2020 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 15-Dec-2017 | $20.3K | $20.3K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-Jan-2017 | Completed | Startup |
GenoPalate Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2B | ||||||||
| Series A-2A | ||||||||
| Series A-1 | 3,100,000 | $0.000010 | 8% | $1.32 | $1.32 | $1.32 | 12.61% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
GenoPalate Comparisons
Industry
Financing
Details
GenoPalate Competitors (1)
One of GenoPalate’s competitors is Everlywell, a Venture Capital-Backed company based in Austin, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Everlywell | Venture Capital-Backed | Austin, TX |
GenoPalate Signals
GenoPalate Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BrightStar Wisconsin Foundation | Venture Capital | Minority | ||
| Startup Milwaukee | Corporation | Minority | ||
| Wisconsin Economic Development | Government | Minority | ||
| gBETA | Accelerator/Incubator | Minority | ||
| gener8tor | Accelerator/Incubator |
GenoPalate FAQs
-
When was GenoPalate founded?
GenoPalate was founded in 2016.
-
Where is GenoPalate headquartered?
GenoPalate is headquartered in Milwaukee, WI.
-
What is the size of GenoPalate?
GenoPalate has 13 total employees.
-
What industry is GenoPalate in?
GenoPalate’s primary industry is Laboratory Services (Healthcare).
-
Is GenoPalate a private or public company?
GenoPalate is a Private company.
-
What is GenoPalate’s current revenue?
The current revenue for GenoPalate is .
-
How much funding has GenoPalate raised over time?
GenoPalate has raised $13.3M.
-
Who are GenoPalate’s investors?
BrightStar Wisconsin Foundation, Startup Milwaukee, Wisconsin Economic Development, gBETA, and gener8tor are 5 of 6 investors who have invested in GenoPalate.
-
Who are GenoPalate’s competitors?
Everlywell is a competitor of GenoPalate.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process